- Home
- REPL vs ARMN Comparison
REPL vs ARMN Comparison
Compare REPL & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ARMN
- Stock Information
- Founded
- REPL 2015
- ARMN 1992
- Country
- REPL United States
- ARMN Canada
- Employees
- REPL N/A
- ARMN N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ARMN
- Sector
- REPL Health Care
- ARMN
- Exchange
- REPL Nasdaq
- ARMN Nasdaq
- Market Cap
- REPL 851.0M
- ARMN 769.7M
- IPO Year
- REPL 2018
- ARMN N/A
- Fundamental
- Price
- REPL $9.00
- ARMN $4.63
- Analyst Decision
- REPL Strong Buy
- ARMN
- Analyst Count
- REPL 6
- ARMN 0
- Target Price
- REPL $20.00
- ARMN N/A
- AVG Volume (30 Days)
- REPL 658.1K
- ARMN 767.8K
- Earning Date
- REPL 05-15-2025
- ARMN 03-12-2025
- Dividend Yield
- REPL N/A
- ARMN N/A
- EPS Growth
- REPL N/A
- ARMN 77.15
- EPS
- REPL N/A
- ARMN 0.14
- Revenue
- REPL N/A
- ARMN $510,604,000.00
- Revenue This Year
- REPL $31.16
- ARMN $49.45
- Revenue Next Year
- REPL N/A
- ARMN $4.63
- P/E Ratio
- REPL N/A
- ARMN $31.85
- Revenue Growth
- REPL N/A
- ARMN 14.06
- 52 Week Low
- REPL $4.92
- ARMN $3.29
- 52 Week High
- REPL $17.00
- ARMN $5.16
- Technical
- Relative Strength Index (RSI)
- REPL 22.80
- ARMN 61.76
- Support Level
- REPL $10.17
- ARMN $4.34
- Resistance Level
- REPL $10.78
- ARMN $4.88
- Average True Range (ATR)
- REPL 0.62
- ARMN 0.21
- MACD
- REPL -0.19
- ARMN 0.02
- Stochastic Oscillator
- REPL 0.00
- ARMN 75.00
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.